Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $593,328 - $833,950
-13,941 Reduced 69.91%
6,001 $338,000
Q4 2023

Feb 12, 2024

BUY
$32.18 - $46.57 $130,940 - $189,493
4,069 Added 25.63%
19,942 $895,000
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $1.12 Million - $1.27 Million
-25,347 Reduced 61.49%
15,873 $722,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $762,346 - $1.61 Million
23,928 Added 138.38%
41,220 $1.79 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $239,196 - $390,904
5,264 Added 43.76%
17,292 $1.14 Million
Q4 2022

Feb 13, 2023

SELL
$41.39 - $81.0 $23,302 - $45,603
-563 Reduced 4.47%
12,028 $541,000
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $155,429 - $242,938
-2,148 Reduced 14.57%
12,591 $912,000
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $556,248 - $727,524
6,379 Added 76.3%
14,739 $1.58 Million
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $13,092 - $17,304
-139 Reduced 1.64%
8,360 $927,000
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $91,231 - $106,110
-763 Reduced 8.24%
8,499 $1.09 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $73,908 - $96,370
-677 Reduced 6.81%
9,262 $1.23 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $658,431 - $759,157
-6,562 Reduced 39.77%
9,939 $1.08 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $164,243 - $202,686
-1,618 Reduced 8.93%
16,501 $1.74 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $14,256 - $17,489
-166 Reduced 0.91%
18,119 $1.89 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $48,226 - $61,327
663 Added 3.76%
18,285 $1.57 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $86,003 - $141,560
-1,791 Reduced 9.23%
17,622 $1.29 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $77,447 - $131,943
2,096 Added 12.1%
19,413 $1.01 Million
Q4 2019

Feb 13, 2020

SELL
$47.06 - $56.64 $130,262 - $156,779
-2,768 Reduced 13.78%
17,317 $970,000
Q3 2019

Nov 13, 2019

BUY
$47.45 - $58.05 $513,219 - $627,868
10,816 Added 116.69%
20,085 $959,000
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $6,163 - $8,510
-157 Reduced 1.67%
9,269 $502,000
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $6,117 - $9,003
205 Added 2.22%
9,426 $381,000
Q4 2018

Feb 13, 2019

SELL
$29.95 - $46.34 $14,795 - $22,891
-494 Reduced 5.08%
9,221 $287,000
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $14,523 - $16,489
362 Added 3.87%
9,715 $442,000
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $98,232 - $107,873
-2,537 Reduced 21.34%
9,353 $392,000
Q1 2018

May 11, 2018

BUY
$39.4 - $47.39 $34,908 - $41,987
886 Added 8.05%
11,890 $489,000
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $11,553 - $13,336
310 Added 2.9%
11,004 $452,000
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $360,922 - $445,618
10,694
10,694 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.